These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6983991)

  • 1. [Active chronic hepatitis with incomplete CREST syndrome: value of anticentromere antibodies].
    Devars du Mayne JF; Yeni P; Harlé X; Chagnon JP; Boulanger F; Brion N
    Gastroenterol Clin Biol; 1982 Nov; 6(11):949. PubMed ID: 6983991
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticentromere antibodies--clinical correlates.
    Wade JP; Sack B; Schur PH
    J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
    Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
    Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticentromere antibody].
    Moroi Y
    Ryumachi; 1989 Apr; 29(2):150-7. PubMed ID: 2788927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR; Trontell MC
    J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticentromere antibodies: clinical and biological significance.
    Fritzler MJ; Ayer LM
    J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-centromere antibody (ACA) and its significance for the diagnosis of CREST syndrome].
    Chen SE; Gu YY; Xu YH
    Zhonghua Nei Ke Za Zhi; 1986 Dec; 25(12):736-8, 776. PubMed ID: 3494576
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antinuclear antibodies in progressive systemic sclerosis].
    Sepúlveda C; Palma S; Guzmán L; Bravo M
    Rev Med Chil; 1986 Aug; 114(8):731-6. PubMed ID: 3554436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of anticentromere antibody assay].
    Moteki S
    Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acrosclerosis, Gougerot-Sjögren syndrome, myxedema and anti-centromere antibodies. 3 cases of this association].
    Balafrej M; Kahn MF; Vigneron AM; Bourgeois P
    Ann Med Interne (Paris); 1987; 138(3):185-8. PubMed ID: 3497597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients.
    Ruffatti A; Artifoni L; Glorioso S; Calligaro A; Doria A; Gambari P; Todesco S
    J Rheumatol; 1985 Oct; 12(5):940-3. PubMed ID: 3878881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticentromere antibody in primary biliary cirrhosis.
    Bernstein RM; Callender ME; Neuberger JM; Hughes GR; Williams R
    Ann Rheum Dis; 1982 Dec; 41(6):612-4. PubMed ID: 7149799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
    Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
    Stolz W; Ring J; Meurer M
    Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.